Palisade Bio News

Analysts' Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE) and Palisade Bio (PALI)

TipRanksApr 17 11:30 ET

Palisade Bio Analyst Ratings

BenzingaApr 16 13:22 ET

Analysts Are Bullish on Top Healthcare Stocks: Inventiva (IVA), Palisade Bio (PALI)

TipRanksMar 28 10:10 ET

Analysts' Top Healthcare Picks: Vaxart (VXRT), Palisade Bio (PALI)

TipRanksJan 31 07:40 ET

Maxim Group Upgrades Palisade Bio to Buy, Announces $1.5 Price Target

BenzingaNov 17, 2023 07:58 ET

Palisade Bio Analyst Ratings

BenzingaNov 17, 2023 07:56 ET

Ladenburg Thalmann Adjusts Price Target on Palisade Bio to $16 From $25, Maintains Buy Rating

MT NewswiresMay 16, 2023 08:59 ET

Ladenburg Thalmann Maintains Buy on Palisade Bio, Lowers Price Target to $16

BenzingaMay 16, 2023 08:23 ET

Maxim Group Keeps Their Buy Rating on Palisade Bio (PALI)

TipRanksMay 13, 2023 10:15 ET

Maxim Group Upgrades Palisade Bio to Buy, Announces $50 Price Target

BenzingaMar 30, 2023 09:22 ET

Watching Palisade Bio; Ladenburg Gives Stock Buy Rating And $25 Price Target Says Spoke to Pali Management, Growing More Confident In The Regulatory Path LB1148 May Take Forward As The Topline Ph2 Data On The Prevention Of Post-surgical Abdominal Adhesion

Benzinga Real-time NewsJan 31, 2023 13:38 ET

Ladenburg Lowers Palisade Bio's Price Target to $1.50 From $5, Maintains Buy Rating

MT NewswiresAug 23, 2022 12:11 ET

Palisade Bio Analyst Ratings

Benzinga Analyst RatingsAug 19, 2022 08:20 ET